Stay updated on KN046 Plus Lenvatinib in NSCLC Clinical Trial
Sign up to get notified when there's something new on the KN046 Plus Lenvatinib in NSCLC Clinical Trial page.

Latest updates to the KN046 Plus Lenvatinib in NSCLC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdds a Record History with versioned study records (Study Record Versions) and related navigation, displaying the sequence of updates to the study record, including dates, versions, and status.SummaryDifference10%

- Check21 days agoChange DetectedA new revision entry v3.6.5 has been added to the study’s history, replacing the previous revision v3.6.4 in the list of changes. This update records the latest system release applied to the history view and confirms the older revision has been superseded.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedVersion 3.6.4 is now listed in the record history, replacing the previous 3.6.3. This reflects a software release updating the ClinicalTrials.gov interface and does not modify study data or page content.SummaryDifference0.1%

- Check57 days agoChange DetectedThe history gains a new revision entry: Revision: v3.6.3, replacing Revision: v3.6.2 in the version list. This indicates a page-wide update to the ClinicalTrials.gov record history rather than a modification to study content.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision entry, Revision: v3.6.2, has been added to the study's record history. The older Revision: v3.6.0 entry has been removed from the history.SummaryDifference0.1%

- Check78 days agoChange DetectedThe study record now shows that recruitment is closed to new participants. The record also includes a new revision tag of v3.6.0, replacing the previous v3.5.5, signaling a recent update batch.SummaryDifference0.7%

Stay in the know with updates to KN046 Plus Lenvatinib in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the KN046 Plus Lenvatinib in NSCLC Clinical Trial page.